Clinicopathological Significance of Human Macrophage Metalloelastase Expression in Esophageal Squamous Cell Carcinoma

Objective: Human macrophage metalloelastase is referred to as matrix metalloproteinase (MMP-12), its function in tumors is contradictory. The current study was undertaken to investigate the role of MMP-12 in esophageal squamous cell carcinoma (SCC). Patients and Methods: We analyzed the levels of MMP-12 mRNA expression in 67 patients with primary esophageal SCC by Northern blot analysis and the tissues were subjected to in situ hybridization analysis for MMP-12. Immunohistochemical staining was performed to detect the macrophages infiltrated in esophageal SCCs. Results: MMP-12 mRNA was detected in 27 of 67 esophageal SCC samples by Northern blot analysis. In situ hybridization and immunohistochemical staining revealed that MMP-12 mRNA signals are located mainly in tumor cells. The frequency of lymph node metastasis was significantly higher in the MMP-12-positive (MMP-12(+)) subgroup than MMP-12-negative (MMP-12(–)) subgroup (p < 0.05); furthermore, invasion was significantly deeper in the MMP- 12(+) subgroup than in the MMP-12(–) subgroup (p < 0.01). MMP-12 mRNA was inversely correlated with prognosis (p < 0.05). However, Cox multivariate analysis revealed that upregulation of MMP-12 was not related to prognosis. Conclusions: MMP-12 gene expression was associated with the progression of esophageal SCC; however, it was not an independent prognostic factor.

[1]  R. Béliveau,et al.  Expression of matrix metalloproteinases and their inhibitors in human brain tumors , 2004, Clinical & Experimental Metastasis.

[2]  B. Nordlinger,et al.  Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  M. Mizumoto,et al.  Mouse macrophage metalloelastase gene transfer into a murine melanoma suppresses primary tumor growth by halting angiogenesis. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  R. Pierce,et al.  Matrix metalloproteinases generate angiostatin: effects on neovascularization. , 1998, Journal of immunology.

[5]  K. Sugimachi,et al.  Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  S. Arii,et al.  Human macrophage metalloelastase gene expression in colorectal carcinoma and its clinicopathologic significance , 2001, Cancer.

[7]  V. Kähäri,et al.  Matrix metalloproteinases and their inhibitors in tumour growth and invasion. , 1999, Annals of medicine.

[8]  T. Ley,et al.  Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[9]  K. Isono,et al.  Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. , 1991, Oncology.

[10]  Y. Sasaguri,et al.  Production onf matrix metalloproteinase‐2 and metalloproteinase‐3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study , 1992, Cancer.

[11]  M. Mizumoto,et al.  Expression of human macrophage metalloelastase gene in hepatocellular carcinoma: Correlation with angiostatin generation and its clinical significance , 1998, Hepatology.

[12]  S. Shapiro,et al.  Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer. , 2000, The Journal of investigative dermatology.

[13]  S. Chandler,et al.  Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein. , 1996, Biochemical and biophysical research communications.

[14]  K. Mimori,et al.  Overexpression of matrix metalloproteinase‐7 mRNA in human colon carcinomas , 1995, Cancer.

[15]  M. Imamura,et al.  Characterization of 21 newly established esophageal cancer cell lines , 1992, Cancer.

[16]  K. Sugimachi,et al.  Multivariate approach for assessing the prognosis of clinical oesophageal carcinoma , 1988, The British journal of surgery.

[17]  L. Matrisian,et al.  Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis , 1995, Cancer and Metastasis Reviews.

[18]  S. Kitano,et al.  Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness , 2000, Gut.

[19]  A. Hanby,et al.  Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. , 1993, Cancer research.

[20]  Motoharu Seiki,et al.  A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.

[21]  Z. Werb,et al.  Mouse macrophage elastase. Purification and characterization as a metalloproteinase. , 1981, The Biochemical journal.

[22]  I. Fidler,et al.  Macrophage-Derived Metalloelastase Is Responsible for the Generation of Angiostatin in Lewis Lung Carcinoma , 1997, Cell.

[23]  M. Karjalainen‐Lindsberg,et al.  Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma , 2001, British Journal of Cancer.

[24]  M. Dardenne Role of thymic peptides as transmitters between the neuroendocrine and immune systems. , 1999, Annals of medicine.

[25]  D. Carter TNM Classification of Malignant Tumors , 1998 .